<p>Tumor molecular profiling is increasingly important for the diagnosis and clinical management of childhood brain tumors, including diffuse midline glioma (DMG). We established a targeted deep sequencing approach using the TruSight Oncology 500 ctDNA exome panel to detect tumor genomic mutations and copy number variations in circulating tumor DNA from children diagnosed with DMG. In this study, we present the sensitivity, specificity, and clinical implications of our liquid biopsy sequencing approach for tumor genome profiling in children with DMG. </p>

Circulating Tumor DNA Sequencing Provides Comprehensive Mutation    Profiling for Pediatric Central Nervous System Tumors

Brain Neoplasms study with Targeted-Capture, WXS data on dbGaP (10 participants)

Circulating Tumor DNA Sequencing Provides Comprehensive Mutation Profiling for Pediatric Central Nervous System Tumors

Description

Applying For Access

Summary